Someone pls help me on all 3 questions would really be appreciated.

What was the total cost and book value of property, plant, and equipment at September 26, 2015? Total Cost $ Book Value $ 22,471 e Textbook and Media X Your answer is incorrect. What was the amount of depreciation and amortization expense for each of the three years 2013-2015? Depreciation and amortization expense 2015 $ 8067 2014 $ ta 6041 2013 ta 4475 X Your answer is incorrect. Using the statement of cash flows, what is the amount of capital spending in 2015 and 2016? 2015 $ 2016 $ CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except number of shares which are reflected in thousands and per share amounts) Years ended September 26, Soptember 27, September 28, 2015 2014 2013 Net sales $ 233,715 $ 182,795 $ 170,910 Cost of sales 140,089 112,258 106,606 Gross margin 93,626 70,537 64,304 Operating expenses: Research and development 8,067 6,041 4,475 Selling, general and administrative 14,329 11,993 10,830 Total operating expenses 22,396 18,034 15,305 Operating income 71.230 52,508 48.999 Other income/expense), net 1.285 980 1,156 Income before provision for income taxes 72,515 53,483 50.155 Provision for income taxes 19,121 13,973 13,118 Net income S 53,394 $ 39,510 $ 37,037 5999 Earnings per share: Basic Diluted $ 9.28 $ 6.49 $ 5.72 $ 9.22 $ 6.45 $ 5.68 Shares used in computing earnings per share: Basic 5,753,421 5,793,069 6,085,572 6,122,663 6,477,320 6,521,634 Diluted Cash dividends declared per share $ 1.98 $ 1.82 $ 1.64 See accompanying Notes to Consolidated Financial Statements. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In millions) Years ended September 26, September 27, September 28 2015 2014 2013 $ 53,394 $ 39,510 $ 37,037 (411) ( (137) ) (112) 2,905 1,390 522 Net income Other comprehensive income/loss): Change in foreign currency translation, net of tax effects of $201, $50 and $35, $, $$, respectively Change in unrealized gains/losses on derivative instruments: Change in fair value of derivatives, net of tax benefit/(expense) of $(441), $(297) and $(351), respectively Adjustment for net (gains) losses realized and included in net income, net of tax expense/(benefit) of $630, $(36) and $255, respectively Total change in unrealized gains/losses on derivative instruments, net of tax Change in unrealized gains/losses on marketable securities: Change in fair value of marketable securities, net of tax benefit/(expense) of $264, $(153) and $458, respectively Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(32), $71 and $82, respectively Total change in unrealized gains/losses on marketable securities, net of tax (3,497) 149 ( (458) (592) 1,539 64 (483) 285 (791) 59 (134) 151 (131) (922) (424) See accompanying Notes to Consolidated Financial Statements. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In millions) Years ended September 26, September 27, September 28, 2015 2014 2013 $ 53,394 $ 39,510 $ 37.037 Net income (411) (137) (112) 2,905 1.390 522 (3,497 149 (458) Other comprehensive income/loss): Change in foreign currency translation, net of tax effects of $201, $50 and $35, $ respectively Change in unrealized gains/losses on derivative instruments: Change in fair value of derivatives, net of tax benefit/(expense) of $(441), $(297) and $(351), respectively Adjustment for net (gains) losses realized and included in net income, net of tax expense/benefit) of $630, $(36) and $255, respectively Total change in unrealized gains/losses on derivative instruments, net of tax Change in unrealized gains/losses on marketable securities: Change in fair value of marketable securities, net of tax benefit/(expense) of $264, $(153) and $458, respectively Adjustment for net (gains) losses realized and included in net income, net of tax expense/ benefit) of $(32), $71 and $82, respectively Total change in unrealized gains/losses on marketable securities, net of tax Total other comprehensive income/(loss) Total comprehensive income (592) 1,539 64 (483) 285 (791) 59 (424) (1,427) 51,967 $ (134) 151 1,553 41,063 $ ERE (131) (922) 1970) 36,067 $ See accompanying Notes to Consolidated Financial Statements. CONSOLIDATED BALANCE SHEETS (In millions, except number of shares which are reflected in thousands and par value) September 26, 2015 September 27 2014 ASSETS: $ Current assets: Cash and cash equivalents Short-term marketable securities Accounts receivable, less allowances of $82 and $86, respectively Inventories Deferred tax assets Vendor non-trade receivables Other current assets Total current assets Long-term marketable securities Property, plant and equipment, net Goodwill Acquired intangible assets, net Other assets Total assets 21,120 $ 20,481 16,849 2,349 5,546 13,494 9,539 89,378 164,065 22,471 5,116 3,893 5,556 290,479 $ 13,844 11,233 17,460 2,111 4,318 9,759 9,806 68,531 130,162 20,624 4,616 4.142 3,764 231,839 $ LIABILITIES AND SHAREHOLDERS' EQUITY: $ $ 35,490 25,181 8,940 8,499 30.196 18,453 8,491 6,308 2.500 0 Current liabilities: Accounts payable Accrued expenses Deferred revenue Commercial paper Current portion of long-term debt Total current liabilities Deferred revenue, non-current Long-term debt Other non-current liabilities Total liabilities Commitments and contingencies Shareholders' equity: Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,578,753 and 5,866,161 shares issued and outstanding, respectively Retained earnings Accumulated other comprehensive income Total shareholders' equity Total liabilities and shareholders' equity 80,610 3,624 53,463 33,427 171,124 63,448 3,031 28,987 24,826 120,292 27,416 23,313 92,284 87,152 (345) 1,082 119,355 111,547 290,479 $ 231,839 See accompanying Notes to Consolidated Financial Statements, CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (In millions, except number of shares which are reflected in thousands) Balances as of September 29, 2012 Net income Accumulated Common Stock and Additional Paid-In Capital Other Total Retained Comprehensivo Shareholders Shares Amount Earnings Income/(Loss) Equity 6,574,458 $ 16,422 $ 101,289 $ 499 $ 118,210 0 0 37,037 0 37,037 0 0 0 1970) (970) 0 0 (10,676) 0 (10,676) (328,837) 0 (22.950) 0 (22.950) 0 2,253 0 0 2.253 48,873 (143) (444) 0 (587) 0 0 1,232 19,764 6,294,494 (471) 104,256 39,510 1.232 123,549 39,510 1,553 0 0 Other comprehensive income/(loss) Dividends and dividend equivalents declared Repurchase of common stock Share-based compensation Common stock issued, net of shares withheld for employee taxes Tax benefit from equity awards, including transfer pricing adjustments Balances as of September 28, 2013 Net income Other comprehensive income/loss) Dividends and dividend equivalents declared Repurchase of common stock Share-based compensation Common stock issued, net of shares withheld for employee taxes Tax benefit from equity awards, including transfer pricing adjustments Balances as of September 27, 2014 Net income Other comprehensive income/loss) 0 0 0 0 1,553 0 0 0 (11,215) ) (45,000) ooo (488,677) 0 (11,215) (45,000) 2,863 0 2,863 0 60,344 (49) (399) 0 (448) 0 0 735 23,313 5,866, 161 0 87,152 53,394 1,082 735 111,547 53,394 (1,427) 0 0 0 0 0 0 0 (1,427) 0 0 0 (1,427) 0 0 0 (1,427) (11,627) (36,026) 3,586 (11,627) (36,026) 0 (325,032) 0 0 0 0 3,586 0 Other comprehensive income/loss) Dividends and dividend equivalents declared Repurchase of common stock Share-based compensation Common stock issued, net of shares withheld for employee taxes Tax benefit from equity awards, including transfer pricing adjustments Balances as of September 26, 2015 37,624 (231) (609) 0 (840) 0 748 0 5,578,753 $ 27,416 $ 92,284 $ 748 119,355 (345) $ See accompanying Notes to Consolidated Financial Statements CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) Years ended September 26, September 27, September 28, 2015 2014 2013 $ 13,844 $ 14,259 $ 10,746 53,394 39,510 37,037 11,257 3,586 7,946 2,863 2,347 6,757 2,253 1,141 1,382 611 (238) (3.735) (179) 5,400 1,042 8,746 (4,232) (76) (2.220) 167 5,938 1,460 6,010 59,713 (2,172) (973) 223 1,080 2,340 1,459 4,521 53,666 81.266 Cash and cash equivalents, beginning of the year Operating activities: Net income Adjustments to reconcile net income to cash generated by operating activities: Depreciation and amortization Share-based compensation expense - Deferred income tax expense Changes in operating assets and liabilities: Accounts receivable, net Inventories Vendor non-trade receivables Other current and non-current assets Accounts payable Deferred revenue Other current and non-current liabilities - Cash generated by operating activities Investing activities: Purchases of marketable securities Proceeds from maturities of marketable securities Proceeds from sales of marketable securities Payments made in connection with business acquisitions, net Payments for acquisition of property, plant and equipment Payments for acquisition of intangible assets Other Cash used in investing activities Financing activities: : Proceeds from issuance of common stock Excess tax benefits from equity awards Taxes paid related to net share settlement of equity awards Dividends and dividend equivalents paid Repurchase of common stock Proceeds from issuance of term debt, net Change in commercial paper, net Cash used in financing activities Increase/(decrease) in cash and cash equivalents Cash and cash equivalents, end of the year Supplemental cash flow disclosure (166,402) 14,538 107,447 (343) (11,247) (241) ( (26) 156,274) (217,128) 18,810 189,301 (3,765) (9,571) (242) 16 (22,579) (148,489) 20,317 104,130 (496) (8,165) (911) (160) (33,774) 543 749 (1,499) (11,561) (35.253) 27.114 2,191 (17,716) 7.276 21.120 $ 730 739 (1,158) (11,126) (45,000) 11,960 530 701 (1.082) (10,564) (22.860) 16,896 0 (16,379) 3,513 14,259 6,306 (37,549) (415) 13,844 $ $